Not available
Quote | Dr. Reddy's Laboratories Ltd (NYSE:RDY)
Last: | $71.14 |
---|---|
Change Percent: | 0.01% |
Open: | $70.9 |
Close: | $71.14 |
High: | $71.3 |
Low: | $70.715 |
Volume: | 116,990 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
News | Dr. Reddy's Laboratories Ltd (NYSE:RDY)
2024-04-02 15:38:04 ET More on Intra-Cellular Therapies Intra-Cellular Therapies Is On Fire Intra-Cellular Therapies, Inc. (ITCI) Q4 2023 Earnings Call Transcript Intra-Cellular Therapies: Buoyant Caplyta Sales And Upcoming MDD Data Support Short-Term 'Buy' I...
Centhaquine is a first-of-its-kind resuscitative agent to treat hypovolemic shock by increasing stroke volume and cardiac output due to an increase in (preload) venous blood return to the heart and a decrease in (afterload) due to arterial dilatation India is the first global territory where ...
Message Board Posts | Dr. Reddy's Laboratories Ltd (NYSE:RDY)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $RDY News Article - Dr. Reddy's Laboratories Announces the Launch of Treprostinil Injec | whytestocks | investorshangout | 04/21/2023 7:50:49 PM |
whytestocks: $RDY News Article - Dr. Reddy's included in Bloomberg Gender-Equality Index for the 6th | whytestocks | investorshangout | 02/08/2023 7:50:46 PM |
whytestocks: $RDY News Article - Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. announce | whytestocks | investorshangout | 05/24/2022 5:50:51 PM |
whytestocks: $RDY News Article - Dr. Reddy's Laboratories Gets Emergency Use Authorisation for Sputn | whytestocks | investorshangout | 04/13/2021 12:50:47 PM |
Breaking News: $RDY Dr. Reddy's Laboratories Announces the | whytestocks | investorshub | 09/26/2020 11:15:26 AM |
News, Short Squeeze, Breakout and More Instantly...
Dr. Reddy's Laboratories Ltd Company Name:
RDY Stock Symbol:
NYSE Market:
Centhaquine is a first-of-its-kind resuscitative agent to treat hypovolemic shock by increasing stroke volume and cardiac output due to an increase in (preload) venous blood return to the heart and a decrease in (afterload) due to arterial dilatation India is the first global territory where ...
Versavo® (bevacizumab) is indicated for the treatment of several types of cancers including metastatic colorectal cancer, advanced non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, advanced cervical cancer, ovarian cancer and metastatic breast ...
2024-03-04 16:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...